Company attributes
Other attributes
Biofourmis is a global health IT start-up in Massachusetts that focuses on personalized care and therapies using digital therapeutics. Founded 2015 in Boston, Massachusetts, United States by Kuldeep Singh Rajput and Wendou Niu, Biofourmis has raised a total of $43.6M in funding over seven rounds. Their latest funding was raised on May 21, 2019 from a Series B round. Biofourmis is funded by eight investors. Aviva Ventures and Openspace Ventures are the most recent investors as of April 2020. The company's platform uses artificial intelligence to integrate and analyze continuous physiology data from clinical grade wearables and to detect personalized patterns that can predict a patient's health deterioration, enabling medical professionals to intervene days before a critical event.
